PCPA – Webinar – Improving Cardiovascular and Renal Outcomes in People with CKD and Type 2 Diabetes

Speaker: Dr Robert Mullan, Consultant Nephrologist, Antrim Area Hospital, Northern Health and Social Care Trust

Key Takeaways:

• CKD is strongly associated with cardiovascular disease and poorer outcomes in patients with diabetes mellitus
• Albuminuria is a very important risk factor for CKD progression and cardiovascular disease
• New drug therapies have been identified to reduce albuminuria and slow CKD progression

• This meeting has been funded by the Boehringer Ingelheim who have had no input into the agenda, speaker selection, presentations or collateral.